Related references
Note: Only part of the references are listed.Gossypol Interferes with Both Type I and Type II Topoisomerase Activities Without Generating Strand Breaks
Muge Senarisoy et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2013)
In vitro and in vivo studies on antitumor effects of gossypol on human stomach adenocarcinoma (AGS) cell line and MNNG induced experimental gastric cancer
G. R. Gunassekaran et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
被撤回的出版物: Gossypol Induces Death Receptor-5 through Activation of the ROS-ERK-CHOP Pathway and Sensitizes Colon Cancer Cells to TRAIL (Retracted article. See vol. 291, pg. 16923, 2016)
Bokyung Sung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Differential growth inhibition and induction of apoptosis by gossypol between HCT116 and HCT116/BAX-/- colorectal cancer cells
Manchao Zhang et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2007)
Nonpeptidic small-molecule inhibitor of Bcl-2 and Bcl-XL, (-)-gossypol, enhances biological effect of genistein against BxPC-3 human pancreatic cancer cell line
RM Mohammad et al.
PANCREAS (2005)
Oral gossypol in the treatment of patients with refractory metastatic breast cancer: A phase I/II clinical trial
C Van Poznak et al.
BREAST CANCER RESEARCH AND TREATMENT (2001)
Share Paper
